Wedbush Brokers Lower Earnings Estimates for FHTX
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – Research analysts at Wedbush reduced their Q2 2025 EPS estimates for shares of Foghorn Therapeutics in a report issued on Wednesday, May 14th. Wedbush analyst R. Driscoll now forecasts that the company will earn ($0.31) per share for the quarter, down from their prior estimate of ($0.28). […]
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – Research analysts at Wedbush reduced their Q2 2025 EPS estimates for shares of Foghorn Therapeutics in a report issued on Wednesday, May 14th. Wedbush analyst R. Driscoll now forecasts that the company will earn ($0.31) per share for the quarter, down from their prior estimate of ($0.28). […]
